{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:47:19Z","timestamp":1790765239950,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,21]],"date-time":"2016-10-21T00:00:00Z","timestamp":1477008000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,10,21]],"date-time":"2016-10-21T00:00:00Z","timestamp":1477008000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"publisher","award":["674-A-12-00020"],"award-info":[{"award-number":["674-A-12-00020"]}],"id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"publisher","award":["674-A-12-00020"],"award-info":[{"award-number":["674-A-12-00020"]}],"id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"publisher","award":["674-A-12-00020"],"award-info":[{"award-number":["674-A-12-00020"]}],"id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"publisher","award":["674-12-00002"],"award-info":[{"award-number":["674-12-00002"]}],"id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"publisher","award":["674-12-00002"],"award-info":[{"award-number":["674-12-00002"]}],"id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"publisher","award":["674-A-12-00029"],"award-info":[{"award-number":["674-A-12-00029"]}],"id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12879-016-1933-0","type":"journal-article","created":{"date-parts":[[2016,10,21]],"date-time":"2016-10-21T03:41:57Z","timestamp":1477021317000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Severe adverse events during second-line tuberculosis treatment in the context of high HIV Co-infection in South Africa: a retrospective cohort study"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0757-4325","authenticated-orcid":false,"given":"Kathryn","family":"Schnippel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca H.","family":"Berhanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Firnhaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norah","family":"Maitisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edina","family":"Sinanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,21]]},"reference":[{"key":"1933_CR1","volume-title":"Global tuberculosis report","author":"World Health Organization (WHO)","year":"2015","unstructured":"World Health Organization (WHO). Global tuberculosis report. Geneva: World Health Organization; 2015."},{"key":"1933_CR2","unstructured":"Statistics South Africa. Mortality and causes of death in South Africa, 2014: Findings from death notification. Pretoria: Statistics South Africa; 2015. \n                    www.statssa.gov.za\n                    \n                  . doi: Statistical release P0309.3."},{"key":"1933_CR3","volume-title":"Definitions and reporting framework for tuberculosis\u20132013 revision","author":"World Health Organization (WHO)","year":"2013","unstructured":"World Health Organization (WHO). Definitions and reporting framework for tuberculosis\u20132013 revision. 2013."},{"key":"1933_CR4","doi-asserted-by":"publisher","DOI":"10.5772\/56396","volume-title":"Management of drug-resistant TB: policy guidelines","author":"Directorate Drug-Resistant TB","year":"2013","unstructured":"Directorate Drug-Resistant TB. Management of drug-resistant TB: policy guidelines. Pretoria: National Department of Health; 2013. doi:\n                    10.5772\/56396\n                    \n                  ."},{"key":"1933_CR5","volume-title":"A practical handbook on the pharmacovigilance of medicines used in the treatment of tuberculosis: enhancing the safety of the TB patient","author":"World Health Organization (WHO)","year":"2012","unstructured":"World Health Organization (WHO). A practical handbook on the pharmacovigilance of medicines used in the treatment of tuberculosis: enhancing the safety of the TB patient. 2012."},{"key":"1933_CR6","doi-asserted-by":"publisher","unstructured":"Wu S, Zhang Y, Sun F, Chen M, Zhou L, Wang N, et al. Adverse events associated with the treatment of multidrug-resistant tuberculosis: a systematic review and meta-analysis. Am J Ther. 2013. doi:\n                    10.1097\/01.mjt.0000433951.09030.5a\n                    \n                  .","DOI":"10.1097\/01.mjt.0000433951.09030.5a"},{"key":"1933_CR7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ijid.2015.09.002","volume":"39","author":"K Schnippel","year":"2015","unstructured":"Schnippel K, Shearer K, Evans D, Berhanu R, Dlamini S, Ndjeka N. Predictors of mortality and treatment success during treatment for rifampicin-resistant tuberculosis within the South African National TB Programme, 2009 to 2011: a cohort analysis of the national case register. Int J Infect Dis. 2015;39:89\u201394. doi:\n                    10.1016\/j.ijid.2015.09.002\n                    \n                  .","journal-title":"Int J Infect Dis"},{"key":"1933_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1371\/journal.pone.0047370","volume":"7","author":"M Arentz","year":"2012","unstructured":"Arentz M, Pavlinac P, Kimerling ME, Horne DJ, Falzon D, Sch\u00fcnemann HJ, et al. Use of anti-retroviral therapy in tuberculosis patients on second-line anti-TB regimens: a systematic review. PLoS One. 2012;7:3\u201312. doi:\n                    10.1371\/journal.pone.0047370\n                    \n                  .","journal-title":"PLoS One"},{"key":"1933_CR9","volume-title":"Guidelines for the programmatic management of drug-resistant tuberculosis. 2011 updat","author":"World Health Organization (WHO)","year":"2011","unstructured":"World Health Organization (WHO). Guidelines for the programmatic management of drug-resistant tuberculosis. 2011 updat. Geneva: World Health Organization; 2011."},{"key":"1933_CR10","volume-title":"Introduction of new drugs and drug regimens for the management of drug-resistant tuberculosis in south africa: policy framework","author":"Directorate Drug-Resistant TB","year":"2015","unstructured":"Directorate Drug-Resistant TB, DR-TB Directorate. Introduction of new drugs and drug regimens for the management of drug-resistant tuberculosis in south africa: policy framework. 11th ed. Pretoria: National Department of Health; 2015.","edition":"11"},{"key":"1933_CR11","unstructured":"South African National Department of Health. Clinical guidelines for the management of HIV and AIDS in adults and adolescents. Pretoria: South African National Department of Health; 2010. Document available from \n                    http:\/\/apps.who.int\/medicinedocs\/documents\/s19153en\/s19153en.pdf\n                    \n                  ."},{"key":"1933_CR12","unstructured":"South African National Department of Health. The South African Antiretroviral Treatment Guidelines. Pretoria: South African National Department of Health; 2013. Document available from \n                    http:\/\/www.sahivsoc.org\/Files\/2013%20ART%20Treatment%20Guidelines%20Final%2025%20March%202013%20corrected.pdf\n                    \n                  ."},{"key":"1933_CR13","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1183\/09031936.00044812","volume":"40","author":"J a Seddon","year":"2012","unstructured":"Seddon J a, Godfrey-Faussett P, Jacobs K, Ebrahim A, Hesseling AC, Schaaf HS. Hearing loss in patients on treatment for drug-resistant tuberculosis. Eur Respir J. 2012;40:1277\u201386. doi:\n                    10.1183\/09031936.00044812\n                    \n                  .","journal-title":"Eur Respir J"},{"key":"1933_CR14","doi-asserted-by":"publisher","first-page":"104","DOI":"10.7196\/samj.7517","volume":"104","author":"U Mehta","year":"2014","unstructured":"Mehta U, Dheda M, Steel G, Blockman M, Ntilivamunda a, Maartens G, et al. Strengthening pharmacovigilance in South Africa. S Afr Med J. 2014;104:104\u20136. doi:\n                    10.7196\/SAMJ.7517\n                    \n                  .","journal-title":"S Afr Med J"},{"key":"1933_CR15","first-page":"1","volume-title":"Division of AIDS table for grading the severity of adult and pediatric adverse events","author":"AIDS Clinical Trials Group","year":"2009","unstructured":"AIDS Clinical Trials Group. Division of AIDS table for grading the severity of adult and pediatric adverse events. 2009. p. 1\u201321."},{"key":"1933_CR16","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"2009","unstructured":"Fine JP, Gray RJ. A Proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 2009;94:496\u2013509.","journal-title":"J Am Stat Assoc"},{"key":"1933_CR17","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1097\/QAI.0b013e31828175ed","volume":"62","author":"JCM Brust","year":"2013","unstructured":"Brust JCM, Shah NS, van der Merwe TL, Bamber S, Ning Y, Heo M, et al. Adverse events in an integrated home-based treatment program for MDR-TB and HIV in KwaZulu-Natal, South Africa. J Acquir Immune Defic Syndr. 2013;62:436\u201340. doi:\n                    10.1097\/QAI.0b013e31828175ed\n                    \n                  .","journal-title":"J Acquir Immune Defic Syndr"},{"key":"1933_CR18","doi-asserted-by":"publisher","first-page":"e58817","DOI":"10.1371\/journal.pone.0058817","volume":"8","author":"M Van der Walt","year":"2013","unstructured":"Van der Walt M, Lancaster J, Odendaal R, Davis JG, Shean K, Farley JE. Serious treatment related adverse drug reactions amongst anti-retroviral na\u00efve MDR-TB patients. PLoS One. 2013;8:e58817. doi:\n                    10.1371\/journal.pone.0058817\n                    \n                  .","journal-title":"PLoS One"},{"key":"1933_CR19","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1365-2710.1987.tb00539.x","volume":"12","author":"A Mathews","year":"1987","unstructured":"Mathews A, Bailie GR. Clinical pharmacokinetics, toxicity and cost effectiveness analysis of aminoglycosides and aminoglycoside dosing services. J Clin Pharm Ther. 1987;12:273\u201391.","journal-title":"J Clin Pharm Ther"},{"key":"1933_CR20","unstructured":"Clayden P, Collins S, Daniels C, Frick M, Harrington M, Horn T, et al. TAG 2015 pipeline report. London: HIV i-Base\/Treatment Action Group; 2015."},{"key":"1933_CR21","doi-asserted-by":"publisher","first-page":"e63057","DOI":"10.1371\/journal.pone.0063057","volume":"8","author":"K Shean","year":"2013","unstructured":"Shean K, Streicher E, Pieterson E, Symons G, van Zyl Smit R, Theron G, et al. Drug-associated adverse events and their relationship with outcomes in patients receiving treatment for extensively drug-resistant tuberculosis in South Africa. PLoS One. 2013;8:e63057. doi:\n                    10.1371\/journal.pone.0063057\n                    \n                  .","journal-title":"PLoS One"},{"key":"1933_CR22","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1056\/NEJMoa1013607","volume":"365","author":"DV Havlir","year":"2011","unstructured":"Havlir DV, Kendall M a, Ive P, Kumwenda J, Swindells S, Qasba SS, et al. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N Engl J Med. 2011;365:1482\u201391. doi:\n                    10.1056\/NEJMoa1013607\n                    \n                  .","journal-title":"N Engl J Med"},{"key":"1933_CR23","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1056\/NEJMoa1013911","volume":"365","author":"F-X Blanc","year":"2011","unstructured":"Blanc F-X, Sok T, Laureillard D, Borand L, Rekacewicz C, Nerrienet E, et al. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N Engl J Med. 2011;365:2187\u201398. doi:\n                    10.1056\/NEJMoa1011205\n                    \n                  .","journal-title":"N Engl J Med"},{"key":"1933_CR24","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1056\/NEJMoa0905848","volume":"362","author":"SS Abdool Karim","year":"2010","unstructured":"Abdool Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C, Gray A, et al. Timing of initiation of antiretoviral drugs during tuberculosis therapy. N Engl J Med. 2010;362:697\u2013706. doi:\n                    10.1056\/NEJMoa0905848\n                    \n                  .","journal-title":"N Engl J Med"},{"key":"1933_CR25","doi-asserted-by":"publisher","first-page":"e1001300","DOI":"10.1371\/journal.pmed.1001300","volume":"9","author":"SD Ahuja","year":"2012","unstructured":"Ahuja SD, Ashkin D, Avendano M, Banerjee R, Bauer M, Bayona JN, et al. Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients. PLoS Med. 2012;9:e1001300. doi:\n                    10.1371\/journal.pmed.1001300\n                    \n                  .","journal-title":"PLoS Med"},{"key":"1933_CR26","volume-title":"National tuberculosis management guidelines 2014","author":"TB DOTS Strategy Coordination","year":"2014","unstructured":"TB DOTS Strategy Coordination. National tuberculosis management guidelines 2014. Pretoria: National Department of Health; 2014. \n                    http:\/\/www.sahivsoc.org\/Files\/NTCP_Adult_TB%20Guidelines%2027.5.2014.pdf\n                    \n                  ."},{"key":"1933_CR27","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2174\/138161207779313731","volume":"13","author":"E Selimoglu","year":"2007","unstructured":"Selimoglu E. Aminoglycoside-induced ototoxicity. Curr Pharm Des. 2007;13:119\u201326. doi:\n                    10.2174\/138161207779313731\n                    \n                  .","journal-title":"Curr Pharm Des"},{"key":"1933_CR28","volume-title":"Introduction of new drugs, drug regimens and management for drug-resistant TB in South Africa: policy framework","author":"Directorate Drug-Resistant TB","year":"2015","unstructured":"Directorate Drug-Resistant TB. Introduction of new drugs, drug regimens and management for drug-resistant TB in South Africa: policy framework. 11th ed. Pretoria: National Department of Health; 2015.","edition":"11"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1933-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-016-1933-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1933-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T11:10:32Z","timestamp":1589454632000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-016-1933-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,21]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1933"],"URL":"https:\/\/doi.org\/10.1186\/s12879-016-1933-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,21]]},"assertion":[{"value":"13 February 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"593"}}